美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
59368-045-68	59368-045	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Praxis, LLC	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	10 mg/1; 5 mg/1; 1000 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (59368-045-68)
59368-045-13	59368-045	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Praxis, LLC	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	10 mg/1; 5 mg/1; 1000 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59368-045-13)
0597-0380-68	0597-0380	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	10 mg/1; 5 mg/1; 1000 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68)
0597-0385-88	0597-0385	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	12.5 mg/1; 2.5 mg/1; 1000 mg/1	1 BOTTLE in 1 CARTON (0597-0385-88) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE
0597-0390-13	0597-0390	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	25 mg/1; 5 mg/1; 1000 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13)
0597-0390-31	0597-0390	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	25 mg/1; 5 mg/1; 1000 mg/1	1 BOTTLE in 1 CARTON (0597-0390-31) / 7 TABLET, EXTENDED RELEASE in 1 BOTTLE
0597-0390-71	0597-0390	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	25 mg/1; 5 mg/1; 1000 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71)
0597-0395-23	0597-0395	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	5 mg/1; 2.5 mg/1; 1000 mg/1	180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0395-23)
0597-0395-82	0597-0395	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	5 mg/1; 2.5 mg/1; 1000 mg/1	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0395-82)
0597-0380-13	0597-0380	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	10 mg/1; 5 mg/1; 1000 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-13)
0597-0385-77	0597-0385	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	12.5 mg/1; 2.5 mg/1; 1000 mg/1	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-77)
0597-0385-86	0597-0385	HUMAN PRESCRIPTION DRUG	Trijardy XR	empagliflozin, linagliptin, metformin hydrochloride	TABLET, EXTENDED RELEASE	ORAL	20200423	N/A	NDA	NDA212614	Boehringer Ingelheim Pharmaceuticals, Inc.	EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE	12.5 mg/1; 2.5 mg/1; 1000 mg/1	180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0385-86)